FFCP PHASE1:Hg19::chr20:50827175..50827187,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene= | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_ncRNA | |||
|HGNC= | |||
|TSSclassifier=strong | |||
|UniProt= | |||
|association_with_transcript=0bp_to_ENST00000454600_5end | |||
|cluster_id=chr20:50827175..50827187,+ | |||
|description=CAGE_peak_2_at_ENST00000454600_5end | |||
|id=chr20:50827175..50827187,+ | |||
|ontology_enrichment_celltype=CL:0002541!1.80e-29!3 | |||
|ontology_enrichment_celltype_v019=CL:0002541;1.36e-21;3!CL:1000415;5.71e-09;2 | |||
|ontology_enrichment_celltype_v019_2=CL:0002541,1.29e-21,3;CL:1000415,6.42e-09,2 | |||
|ontology_enrichment_development_v019=UBERON:0009117;4.81e-07;10!UBERON:0005564;4.81e-07;10 | |||
|ontology_enrichment_disease=DOID:1036!1.84e-19!8;DOID:1240!1.92e-08!39;DOID:8692!1.37e-07!31 | |||
|ontology_enrichment_disease_v019=DOID:1036;1.82e-30;8!DOID:1240;1.44e-09;39!DOID:8692;2.24e-08;31 | |||
|ontology_enrichment_disease_v019_2=DOID:1036,1.57e-30,8;DOID:1240,8.42e-10,39;DOID:8692,3.95e-08,31;DOID:2531,1.73e-07,51;DOID:0060083,1.73e-07,51 | |||
|ontology_enrichment_uberon=UBERON:0000476!1.80e-29!3;UBERON:0000920!1.80e-29!3;UBERON:0003124!4.21e-22!7;UBERON:0005631!6.20e-17!14;UBERON:0000158!6.20e-17!14;UBERON:0000478!8.59e-14!24;UBERON:0001282!2.79e-11!1;UBERON:0009842!2.79e-11!1;UBERON:0003704!2.79e-11!1;UBERON:0001171!2.79e-11!1;UBERON:0001172!2.79e-11!1;UBERON:0000473!2.86e-11!8;UBERON:0003135!2.45e-08!11 | |||
|ontology_enrichment_uberon_v019=UBERON:0003124;1.36e-21;3!UBERON:0000920;1.36e-21;3!UBERON:0001282;7.00e-17;1!UBERON:0009842;7.00e-17;1!UBERON:0003704;7.00e-17;1!UBERON:0001171;7.00e-17;1!UBERON:0001172;7.00e-17;1!UBERON:0002294;9.11e-10;7!UBERON:0001173;9.11e-10;7!UBERON:0000473;1.37e-08;8!UBERON:0005631;3.94e-07;10!UBERON:0000158;3.94e-07;10 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000920,1.29e-21,3;UBERON:0001282,5.53e-17,1;UBERON:0009842,5.53e-17,1;UBERON:0003704,5.53e-17,1;UBERON:0001171,5.53e-17,1;UBERON:0001172,5.53e-17,1;UBERON:0003124,7.99e-10,7;UBERON:0000473,1.53e-08,8;UBERON:0002294,8.60e-08,9;UBERON:0001173,8.60e-08,9;UBERON:0004912,8.60e-08,9 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.68507104770311,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.239624855491583,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.309123034943167,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.470719003883896,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.41072388765857,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.835218521685727,0,0,0,0,0,0,0,4.56917875537661,0,0.95497793895076,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.78556634557405,0,0,0,5.42301971544263,0.549585560411174,3.19820865611181,0,0,0,2.70714792740617,2.54881294613061,3.18861015254101,3.60532092175952,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.04603516955828,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.887023701626388,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.509944148709909,0,0,0,2.34913964476542,4.28742608249886,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p2@ENST00000454600 | |||
}} |
Latest revision as of 15:25, 28 July 2015
Short description: | p2@ENST00000454600 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_2_at_ENST00000454600_5end |
Coexpression cluster: | NA |
Association with transcript: | 0bp_to_ENST00000454600_5end |
EntrezGene: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
chorionic membrane mesenchymal stem cell | 1.29e-21 | 3 |
epithelial cell of gall bladder | 6.42e-09 | 2 |
Ontology term | p-value | n |
---|---|---|
egg chorion | 1.29e-21 | 3 |
intralobular bile duct | 5.53e-17 | 1 |
acinus | 5.53e-17 | 1 |
intrahepatic bile duct | 5.53e-17 | 1 |
portal lobule | 5.53e-17 | 1 |
hepatic acinus | 5.53e-17 | 1 |
chorion | 7.99e-10 | 7 |
testis | 1.53e-08 | 8 |
biliary system | 8.60e-08 | 9 |
biliary tree | 8.60e-08 | 9 |
biliary bud | 8.60e-08 | 9 |
Ontology term | p-value | n |
---|---|---|
chronic leukemia | 1.57e-30 | 8 |
leukemia | 8.42e-10 | 39 |
myeloid leukemia | 3.95e-08 | 31 |
hematologic cancer | 1.73e-07 | 51 |
immune system cancer | 1.73e-07 | 51 |